CD1B
T-cell surface glycoprotein CD1b
Also known as: CD1, CD1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29016
- Gene
- CD1B
- Ensembl
- ENSG00000158485
- Chromosome
- 1
- Canonical length
- 333 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
333 residues, UniProt reviewed canonical sequence.
>P29016|CD1B
1 MLLLPFQLLA VLFPGGNSEH AFQGPTSFHV IQTSSFTNST WAQTQGSGWL DDLQIHGWDS
61 DSGTAIFLKP WSKGNFSDKE VAELEEIFRV YIFGFAREVQ DFAGDFQMKY PFEIQGIAGC
121 ELHSGGAIVS FLRGALGGLD FLSVKNASCV PSPEGGSRAQ KFCALIIQYQ GIMETVRILL
181 YETCPRYLLG VLNAGKADLQ RQVKPEAWLS SGPSPGPGRL QLVCHVSGFY PKPVWVMWMR
241 GEQEQQGTQL GDILPNANWT WYLRATLDVA DGEAAGLSCR VKHSSLEGQD IILYWRNPTS
301 IGSIVLAIIV PSLLLLLCLA LWYMRRRSYQ NIPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 492 nTPM
Expression across tissuesHPA
Tissue
- thymus: 492 nTPM
- skin: 3.1 nTPM
- rectum: 2.5 nTPM
- lymph node: 2.1 nTPM
- tonsil: 1.3 nTPM
- appendix: 1.2 nTPM
Single-cell type
- cdc: 83 nCPM
- macrophages: 4.9 nCPM
- monocytes: 2.3 nCPM
- hofbauer cells: 0.5 nCPM
- neutrophils: 0.5 nCPM
- monocyte progenitors: 0.4 nCPM
Immune cell
- myeloid DC: 19 nTPM
- classical monocyte: 3.3 nTPM
- intermediate monocyte: 2.8 nTPM
- total PBMC: 0.8 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.93
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation, endogenous lipid antigen via MHC class Ib
- antigen processing and presentation, exogenous lipid antigen via MHC class Ib
- immune response
- positive regulation of T cell mediated cytotoxicity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC class I-like antigen recognition-like
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- MHC class I-like antigen recognition-like superfamily
- Antigen-presenting and immune regulatory MHC class I-related
- Immunoglobulin C1-set domain
- MHC-I family domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD1B as an antibody target. Whether an autoantibody or antibody against CD1B could matter depends on whether native CD1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD1B is annotated at the cell surface, where native CD1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...